Intelligence Feed event · Equity · 2026-09-18

    Centene posts $2.51 Q2 EPS as Medicaid rolls shrink 8%-9% in 2026

    Question

    Centene posts $2.51 Q2 EPS as Medicaid rolls shrink 8%-9% in 2026

    Direct answer

    Centene posted adjusted EPS of $2.51 for Q2 2026, marking a operational turnaround from a loss in the corresponding prior-year quarter. The performance reflected tighter medical cost controls and improved execution. The company reiterated guidance for an 8% to 9% drop in Medicaid enrollment for 2026 as state redeterminations finalize, with margin gains in individual Marketplace and Medicare books balancing top-line attrition.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-18
    Published
    2026-10-20
    Revision
    1 · 2026-10-21

    Cite as: Market Ontology, “Centene posts $2.51 Q2 EPS as Medicaid rolls shrink 8%-9% in 2026”, revision 1, evidence through 2026-09-18. https://marketontology.com/market-events/2026-09-18/centene-posts-2-51-q2-eps-as-medicaid-rolls-shrink-8-9-in-2026-45273a

    EQUITY
    Centene posts $2.51 Q2 EPS as Medicaid rolls shrink 8%-9% in 2026
    Centene posted adjusted EPS of $2.51 for Q2 2026, marking a operational turnaround from a loss in the corresponding prior-year quarter. The performance reflected tighter medical cost controls and improved execution. The company reiterated guidance for an 8% to 9% drop in Medicaid enrollment for 2026 as state redeterminations finalize, with margin gains in individual Marketplace and Medicare books balancing top-line attrition.
    CNCUNH
    Impact
    65
    SEP 18
    SIG
    85%
    CNCUNH
    Centene posts $2.51 Q2 EPS as Medicaid rolls shrink 8%-9% in 2026
    Centene posted adjusted EPS of $2.51 for Q2 2026, marking a operational turnaround from a loss in the corresponding prior-year quarter. The performance reflected tighter medical cost controls and improved execution. The company reiterated guidance for an 8% to 9% drop in Medicaid enrollment for 2026 as state redeterminations finalize, with margin gains in individual Marketplace and Medicare books balancing top-line attrition.
    → Underwriting margin improvements across Marketplace and Medicare lines offset an 8% to 9% Medicaid membership decline to restore CNC adjusted EPS to $2.51.
    Impact
    Centene posted adjusted EPS of $2.51 for Q2 2026, marking a operational turnaround from a loss in the corresponding prior-year quarter. The performance reflected tighter medical cost controls and improved execution. The company reiterated guidance for an 8% to 9% drop in Medicaid enrollment for 2026 as state redeterminations finalize, with margin gains in individual Marketplace and Medicare books balancing top-line attrition.
    Affected
    CNCUNH
    Transmission
    Underwriting margin improvements across Marketplace and Medicare lines offset an 8% to 9% Medicaid membership decline to restore CNC adjusted EPS to $2.51.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    CNCcommercial margin expansion offsetting Medicaid volume lossUp1-4wReported Q2 EPS of $2.51 and projected 8%-9% Medicaid membership decline.
    UNHmanaged care medical loss ratio read-throughWatch1-4wPeer managed care organization subject to broad medical cost trends.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    CNCUpdisagreed65.11 2026-09-18-0.18%-5.05%Pending
    UNHWatch376.90 2026-09-18+0.18%-0.08%+6.51%

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month